ECMO: Optimization of Its Use

Renzo Loyaga Rendon921 enrolled

Overview

To create a local registry for ECMO patients.

To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.

Study Type

OBSERVATIONAL

Enrollment

921

Conditions

Extracorporeal Membrane Oxygenation Complication

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \>18 * requiring ECMO. For the control,Patients without ECMO admited to ICU. Exclusion Criteria: * Age\<18 * Known prisoner of the state

Locations (1)

Spectrum Health

Grand Rapids, Michigan, United States

Outcomes

Primary Outcomes

All cause mortality

Time frame: 1 year

Secondary Outcomes

all cause mortality

Time frame: 48 hours

In-house mortality

Time frame: 30 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.